BioEclipse Therapeutics Company

BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology.
Technology: Cell-based gene therapy
Industry: Private
Headquarters: San Francisco, California, United States
Founded Date: 2006-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 6
Total Funding: 15699689
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-04-26
Last Funding Type: Grant

Visit Website
Register and Claim Ownership